INS and metabolic syndrome: HFD-fed mice exhibited increased fasting glucose, impaired glucose and insulin tolerance, dyslipidemia, elevated leptin, β-amylase, hepatic mitochondrial oxidative stress, and liver enzymes, alongside decreased fasting insulin, β-cell activity, adiponectin, and islet insulin secretion.